Patents by Inventor Michael F. Powell

Michael F. Powell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COATED SUBSTRATE
    Publication number: 20240132747
    Abstract: A coated substrate comprising a coating extending over at least a part of the substrate. The coating is obtainable from a coating composition comprising (a) a polymeric binder; and (b) a feathering reducing agent comprising a carboxylic acid reactive functional group. The coated portion of the substrate comprises a pretreatment layer. The pretreatment layer is obtainable from a pretreatment composition that comprises a trivalent chromium compound. The invention extends to a method of coating a pre-treated substrate and a coated package, such as a metal can.
    Type: Application
    Filed: January 28, 2022
    Publication date: April 25, 2024
    Applicant: PPG Industries Ohio, Inc.
    Inventors: Adam Bradley Powell, Jr., Elzen Kurpejovic, Fengshuo Hu, Carl A. Seneker, Wenchao Zhang, Hongying Zhou, Edward R. Millero, Jr., Dennis A. Simpson, Michael G. Olah, Rudolf Baumgarten, Kareem Kaleem, Nigel F Masters, William H. Retsch, Jr.
  • COATING COMPOSITION
    Publication number: 20240101860
    Abstract: A coating composition comprising (a) a polyester binder material; and (b) a feathering reducing agent. The feathering reducing agent is selected from (i) an acrylic feathering reducing agent comprising a functional group selected from hydroxyl, epoxide, phosphatized epoxide and/or acid-functional; (ii) a hydroxy-functional polyester feathering reducing agent; (iii) a feathering reducing agent comprising a functional group selected from amine, amide, imine and/or nitrile; (iv) a phosphatized epoxy feathering reducing agent; (v) a phenolic resin feathering reducing agent; and/or (vi) a feathering reducing agent comprising an oxazolyl functional group. The invention extends to a substrate coated with the coating composition and use of the coating composition to reduce feathering.
    Type: Application
    Filed: January 28, 2022
    Publication date: March 28, 2024
    Applicant: PPG Industries Ohio, Inc.
    Inventors: Adam Bradley Powell, Jr., Elzen Kurpejovic, Fengshuo Hu, Carl A. Seneker, Wenchao Zhang, Hongying Zhou, Edward R. Millero, Jr., Dennis A. Simpson, Michael G. Olah, Rudolf Baumgarten, Kareem Kaleem, Nigel F Masters, William H. Retsch, Jr.
  • Stabilizing formulation for NGF
    Patent number: 6964947
    Abstract: Formulations are provided comprising NGF and acetate-containing buffer from pH 5 to 6 that provide enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function.
    Type: Grant
    Filed: July 18, 2000
    Date of Patent: November 15, 2005
    Assignee: Genentech, Inc.
    Inventors: Linda R. De Young, Xanthe M. Lam, Tue H. Nguyen, Michael F. Powell
  • Stabilizing formulation for NGF
    Publication number: 20040097417
    Abstract: Formulations are provided comprising NGF and acetate-containing buffer from pH 5 to 6 that provide enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function.
    Type: Application
    Filed: November 6, 2003
    Publication date: May 20, 2004
    Inventors: Linda R. DeYoung, Xanthe M. Lam, Tue H. Nguyen, Michael F. Powell
  • Stabilizing formulation for NGF
    Patent number: 6090781
    Abstract: Formulations are provided comprising NGF and acetate-containing buffer from pH 5 to 6 that provide enhanced stability of NGF for use in promoting nerve cell growth, repair, survival, differentiation, maturation or function.
    Type: Grant
    Filed: November 6, 1996
    Date of Patent: July 18, 2000
    Assignee: Genentech, Inc.
    Inventors: Linda R. DeYoung, Xanthe M. Lam, Tue H. Nguyen, Michael F. Powell
  • Immunosuppressant peptides
    Patent number: 5679640
    Abstract: Peptide compositions are provided which bind MHC molecules of interest and inhibit T cell activation. The peptide compositions of the present invention comprise various isosteres of naturally occurring amino acid sequences. Such compositions may be used to treat diseases associated with particular DR alleles, including autoimmune diseases such as rheumatoid arthritis.
    Type: Grant
    Filed: March 8, 1995
    Date of Patent: October 21, 1997
    Assignees: Cytel Corporation, Sandoz Ltd.
    Inventors: Federico C. A. Gaeta, Michael F. Powell, Howard M. Grey, Alessandro D. Sette, Thomas S. Arrhenius